Development of a second‐generation oncolytic Herpes simplex virus expressing TNFα for cancer therapy

Overview of attention for article published in Journal of Gene Medicine - Gene Therapy Clinical Trial Database, January 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 11 patents

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 11 patents that reference this research output.

Multimodal trail molecules expressed in T cells

Grant US-10676515-B2

United States of America

09 Jun 2020

Oncolytic virus therapy for resistant tumors

Grant US-10633636-B2

United States of America

28 Apr 2020

ONCOLYTIC VIRUS THERAPY FOR RESISTANT TUMORS

Application EP-3473708-A1

European Patent Office

24 Apr 2019

Methods for treating cancer with EGFR nanobodies linked to DR5 binding moieties

Grant US-10130680-B2

United States of America

20 Nov 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 7 additional patents.